Literature DB >> 29985171

Clarin-1 gene transfer rescues auditory synaptopathy in model of Usher syndrome.

Didier Dulon1,2, Samantha Papal1,3,4, Pranav Patni1,3,4, Matteo Cortese1,3,4, Philippe Fy Vincent1,2, Margot Tertrais1,2, Alice Emptoz1,3,4, Abdelaziz Tlili1,3,4, Yohan Bouleau1,2, Vincent Michel1,3,4, Sedigheh Delmaghani1,3,4, Alain Aghaie1,3,4, Elise Pepermans1,3,4, Olinda Alegria-Prevot1,3,4, Omar Akil5, Lawrence Lustig6, Paul Avan7, Saaid Safieddine1,3,4,8, Christine Petit1,3,4,9, Aziz El-Amraoui1,3,4.   

Abstract

Clarin-1, a tetraspan-like membrane protein defective in Usher syndrome type IIIA (USH3A), is essential for hair bundle morphogenesis in auditory hair cells. We report a new synaptic role for clarin-1 in mouse auditory hair cells elucidated by characterization of Clrn1 total (Clrn1ex4-/-) and postnatal hair cell-specific conditional (Clrn1ex4fl/fl Myo15-Cre+/-) knockout mice. Clrn1ex4-/- mice were profoundly deaf, whereas Clrn1ex4fl/fl Myo15-Cre+/- mice displayed progressive increases in hearing thresholds, with, initially, normal otoacoustic emissions and hair bundle morphology. Inner hair cell (IHC) patch-clamp recordings for the 2 mutant mice revealed defective exocytosis and a disorganization of synaptic F-actin and CaV1.3 Ca2+ channels, indicative of a synaptopathy. Postsynaptic defects were also observed, with an abnormally broad distribution of AMPA receptors associated with a loss of afferent dendrites and defective electrically evoked auditory brainstem responses. Protein-protein interaction assays revealed interactions between clarin-1 and the synaptic CaV1.3 Ca2+ channel complex via the Cavβ2 auxiliary subunit and the PDZ domain-containing protein harmonin (defective in Usher syndrome type IC). Cochlear gene therapy in vivo, through adeno-associated virus-mediated Clrn1 transfer into hair cells, prevented the synaptic defects and durably improved hearing in Clrn1ex4fl/fl Myo15-Cre+/- mice. Our results identify clarin-1 as a key organizer of IHC ribbon synapses, and suggest new treatment possibilities for USH3A patients.

Entities:  

Keywords:  Calcium channels; Gene therapy; Neuroscience; Synapses

Mesh:

Substances:

Year:  2018        PMID: 29985171      PMCID: PMC6063508          DOI: 10.1172/JCI94351

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain.

Authors:  Filip Van Petegem; Kimberly A Clark; Franck C Chatelain; Daniel L Minor
Journal:  Nature       Date:  2004-05-12       Impact factor: 49.962

2.  Direct interaction of CaVβ with actin up-regulates L-type calcium currents in HL-1 cardiomyocytes.

Authors:  Gabriel Stölting; Regina Campos de Oliveira; Raul E Guzman; Erick Miranda-Laferte; Rachel Conrad; Nadine Jordan; Silke Schmidt; Johnny Hendriks; Thomas Gensch; Patricia Hidalgo
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

3.  Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G.

Authors:  Alice Emptoz; Vincent Michel; Andrea Lelli; Omar Akil; Jacques Boutet de Monvel; Ghizlene Lahlou; Anaïs Meyer; Typhaine Dupont; Sylvie Nouaille; Elody Ey; Filipa Franca de Barros; Mathieu Beraneck; Didier Dulon; Jean-Pierre Hardelin; Lawrence Lustig; Paul Avan; Christine Petit; Saaid Safieddine
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-23       Impact factor: 11.205

4.  Lateral mobility of presynaptic L-type calcium channels at photoreceptor ribbon synapses.

Authors:  Aaron J Mercer; Minghui Chen; Wallace B Thoreson
Journal:  J Neurosci       Date:  2011-03-23       Impact factor: 6.167

5.  Alternative splice variants of the USH3A gene Clarin 1 (CLRN1).

Authors:  Hanna Västinsalo; Reetta Jalkanen; Astra Dinculescu; Juha Isosomppi; Scott Geller; John G Flannery; William W Hauswirth; Eeva-Marja Sankila
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

6.  The giant spectrin βV couples the molecular motors to phototransduction and Usher syndrome type I proteins along their trafficking route.

Authors:  Samantha Papal; Matteo Cortese; Kirian Legendre; Nasrin Sorusch; Joseph Dragavon; Iman Sahly; Spencer Shorte; Uwe Wolfrum; Christine Petit; Aziz El-Amraoui
Journal:  Hum Mol Genet       Date:  2013-05-23       Impact factor: 6.150

7.  Impairment of Vision in a Mouse Model of Usher Syndrome Type III.

Authors:  Guilian Tian; Richard Lee; Philip Ropelewski; Yoshikazu Imanishi
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

8.  Disruption of the presynaptic cytomatrix protein bassoon degrades ribbon anchorage, multiquantal release, and sound encoding at the hair cell afferent synapse.

Authors:  Zhizi Jing; Mark A Rutherford; Hideki Takago; Thomas Frank; Anna Fejtova; Darina Khimich; Tobias Moser; Nicola Strenzke
Journal:  J Neurosci       Date:  2013-03-06       Impact factor: 6.167

9.  Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3.

Authors:  T Joensuu; R Hämäläinen; B Yuan; C Johnson; S Tegelberg; P Gasparini; L Zelante; U Pirvola; L Pakarinen; A E Lehesjoki; A de la Chapelle; E M Sankila
Journal:  Am J Hum Genet       Date:  2001-08-27       Impact factor: 11.025

10.  Clarin-1 acts as a modulator of mechanotransduction activity and presynaptic ribbon assembly.

Authors:  Oluwatobi Ogun; Marisa Zallocchi
Journal:  J Cell Biol       Date:  2014-11-03       Impact factor: 10.539

View more
  39 in total

Review 1.  Gene therapy for hearing loss.

Authors:  Ryotaro Omichi; Seiji B Shibata; Cynthia C Morton; Richard J H Smith
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

2.  Viral Transfer of Mini-Otoferlins Partially Restores the Fast Component of Exocytosis and Uncovers Ultrafast Endocytosis in Auditory Hair Cells of Otoferlin Knock-Out Mice.

Authors:  Margot Tertrais; Yohan Bouleau; Alice Emptoz; Séverin Belleudy; R Bryan Sutton; Christine Petit; Saaid Safieddine; Didier Dulon
Journal:  J Neurosci       Date:  2019-03-04       Impact factor: 6.167

3.  The Genetics of Variation of the Wave 1 Amplitude of the Mouse Auditory Brainstem Response.

Authors:  Ely Cheikh Boussaty; Danielle Gillard; Joel Lavinsky; Pezhman Salehi; Juemei Wang; Aline Mendonça; Hooman Allayee; Uri Manor; Rick Adam Friedman
Journal:  J Assoc Res Otolaryngol       Date:  2020-08-05

Review 4.  Advances in genome editing for genetic hearing loss.

Authors:  Ning Ding; Sangsin Lee; Matan Lieber-Kotz; Jie Yang; Xue Gao
Journal:  Adv Drug Deliv Rev       Date:  2020-05-07       Impact factor: 15.470

Review 5.  Usher syndrome IIIA: a review of the disorder and preclinical research advances in therapeutic approaches.

Authors:  Azmi Marouf; Benjamin Johnson; Kumar N Alagramam
Journal:  Hum Genet       Date:  2022-03-23       Impact factor: 4.132

Review 6.  Adeno-associated virus gene replacement for recessive inner ear dysfunction: Progress and challenges.

Authors:  Charles Askew; Wade W Chien
Journal:  Hear Res       Date:  2020-03-18       Impact factor: 3.208

Review 7.  Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.

Authors:  Michelle L Hastings; John V Brigande
Journal:  Hear Res       Date:  2020-03-05       Impact factor: 3.208

Review 8.  Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges.

Authors:  Shahar Taiber; Karen B Avraham
Journal:  Neurosci Lett       Date:  2019-10-03       Impact factor: 3.046

Review 9.  Genetic etiology of hereditary hearing loss in the Gulf Cooperation Council countries.

Authors:  Abdullah Al Mutery; Mona Mahfood; Jihen Chouchen; Abdelaziz Tlili
Journal:  Hum Genet       Date:  2021-08-02       Impact factor: 4.132

10.  Gene editing in a Myo6 semi-dominant mouse model rescues auditory function.

Authors:  Yuanyuan Xue; Xinde Hu; Daqi Wang; Di Li; Yige Li; Fang Wang; Mingqian Huang; Xi Gu; Zhijiao Xu; Jinan Zhou; Jinghan Wang; Renjie Chai; Jun Shen; Zheng-Yi Chen; Geng-Lin Li; Hui Yang; Huawei Li; Erwei Zuo; Yilai Shu
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.